The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Similar Effectiveness of Paroxetine, Fluoxetine, and Sertraline in Primary Care: A Randomized Trial
Abstract
CONTEXT: Selective serotonin reuptake inhibitors (SSRIs) are the most commonly prescribed class of antidepressant, yet it is not known whether one SSRI is more effective than another. OBJECTIVE: To compare the effectiveness of 3 SSRIs (paroxetine, fluoxetine, and sertraline) in depressed primary care patients. DESIGN: Open-label, randomized, intention-to-treat trial, with patient enrollment occurring in April-November 1999. SETTING: Thirty-seven clinics in 2 US primary care research networks. PATIENTS: A total of 573 depressed adult patients for whom their primary care physician thought that antidepressant therapy was warranted and who completed a baseline interview. INTERVENTIONS: Patients were randomly assigned to receive paroxetine (n = 189), fluoxetine (n = 193), or sertraline (n = 191) for 9 months. Primary care physicians were allowed to switch patients to a different SSRI or non-SSRI antidepressant if they did not adequately respond to or tolerate the initial SSRI. MAIN OUTCOME MEASURES: The primary outcome measure was change in the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) Mental Component Summary score (range, 0-100), compared across treatment groups at 1, 3, 6, and 9 months. Secondary outcomes included other depression and psychological measures, multiple measures of social and work functioning, and other domains of health-related quality of life, such as physical functioning, concentration and memory, vitality, bodily pain, sleep, and sexual functioning. RESULTS: Follow-up interviews were successfully completed in 94% of patients at 1 month, 87% at 3 months, 84% at 6 months, and 79% at 9 months. Responses to the 3 SSRIs were comparable on all measures and at all time points. The mean change in the SF-36 Mental Component Summary score at 9 months was + 15.8 in the paroxetine group, + 15.1 in the fluoxetine group, and + 17.4 in the sertraline group. The drugs were also associated with similar incidences of adverse effects and discontinuation rates. CONCLUSIONS: The SSRI antidepressants paroxetine, fluoxetine, and sertraline were similar in effectiveness for depressive symptoms as well as multiple domains of health-related quality of life over the entire 9 months of this trial.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Analysis With Missing Data
Lahiff, M., Little, R. J. A., & Rubin, D. B. (1989) · Journal of the American Statistical Association · doi:10.2307/2289883 · Cited by 17,265
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370
SF-36 health survey: Manual and interpretation guide
Ware, J. (2003) · Medical Entomology and Zoology · Cited by 11,424
Spitzer, R. L. (1999) · JAMA · doi:10.1001/jama.282.18.1737 · Cited by 9,802
Cohen, J. (1992) · Psychological Bulletin · doi:10.1037//0033-2909.112.1.155 · Cited by 8,771
(1994) · Medical Entomology and Zoology · Cited by 4,156
Measuring Functioning and Well-Being: The Medical Outcomes Study Approach
Stewart, A., & Ware, J. (1992) · doi:10.7249/cb361 · Cited by 2,689
Rectangular Confidence Regions for the Means of Multivariate Normal Distributions
Šidák, Z. (1967) · Journal of the American Statistical Association · doi:10.1080/01621459.1967.10482935 · Cited by 2,639
Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study
Spitzer, R. L. (1994) · JAMA · doi:10.1001/jama.272.22.1749 · Cited by 2,635
Performance of a Five-Item Mental Health Screening Test
Berwick, D. M., Murphy, J. M., Goldman, P. A., Ware, J. E., Barsky, A. J., & Weinstein, M. C. (1991) · Medical Care · doi:10.1097/00005650-199102000-00008 · Cited by 1,660
A Multifaceted Intervention to Improve Treatment of Depression in Primary Care
Katon, W. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830100072009 · Cited by 835 · cited 2×
“Lost to follow-up while taking randomized drug 18 (10) 21 (11) 23 (12)”
BackgroundTreatments of Depression and the Functional Capacity to Work
Mintz, J. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820100005001 · Cited by 563
Functional Status Questionnaire
Sisto, S. A. (2017) · Encyclopedia of Clinical Neuropsychology · doi:10.1007/978-3-319-56782-2_1938-2 · Cited by 449
Williams, J. W., Mulrow, C. D., Chiquette, E., Noël, P. H., Aguilar, C., & Cornell, J. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-9-200005020-00011 · Cited by 423
Simon, G. E. (1996) · JAMA · doi:10.1001/jama.275.24.1897 · Cited by 294
Telephone assessment of depression severity
Simon, G. E., Revicki, D., & VonKorff, M. (1993) · Journal of Psychiatric Research · doi:10.1016/0022-3956(93)90035-z · Cited by 220
Worst-Rank Score Analysis with Informatively Missing Observations in Clinical Trials
Lachin, J. M. (1999) · Controlled Clinical Trials · doi:10.1016/s0197-2456(99)00022-7 · Cited by 164
Detecting Selection Bias in Randomized Clinical Trials
Berger, V. W., & Exner, D. V. (1999) · Controlled Clinical Trials · doi:10.1016/s0197-2456(99)00014-8 · Cited by 163
Simon, G. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)00141-c · Cited by 150
Pharmacologic Treatment of Acute Major Depression and Dysthymia: Clinical Guideline, Part 1
Snow, V. T., Lascher, S., & Mottur-Pilson, C. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-9-200005020-00010 · Cited by 143
Symptom Indexes to Assess Outcomes of Treatment for Early Prostate Cancer
Clark, J. A., & Talcott, J. A. (2001) · Medical Care · doi:10.1097/00005650-200110000-00009 · Cited by 126
Safety and tolerability of the new antidepressants.
Nelson, J. C. (1997) · PubMed · Cited by 76
Acute Effects of Fluoxetine Versus
Heiligenstein, J. H., Ware, J. E., Beusterien, K. M., Roback, P., Andrejasich, C. M., & Tollefson, G. D. (1995) · International Psychogeriatrics · doi:10.1017/s1041610295002407 · Cited by 67
Antidepressant Medication Change in a Clinical Treatment Setting
Nurnberg, H. G., Thompson, P. M., & Hensley, P. L. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0902 · Cited by 54
Fatal toxicity associated with antidepressant use in primary care
Mason, J. M., Freemantle, N., & Eccles, M. (2000) · Europe PMC (PubMed Central) · doi:10.25405/ncl.34661673 · Cited by 28
Collaborative Management to Achieve Treatment Guidelines: Impact on Depression in Primary Care
Katon, W. (1995) · JAMA · doi:10.1001/jama.1995.03520370068039 · Cited by 6
Derivation of Physical and Mental Health Composite Indices in the HIV Outcomes Study
Hays, R. D., Cunningham, W. E., & Shapiro, M. F. (1997) · Cited by 4
Self-citation
Cited by
Kroenke, K., Spitzer, R. L., Williams, J. B. W., & Löwe, B. (2010) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2010.03.006 · Cited by 4,057
Self-citationMonitoring Depression Treatment Outcomes With the Patient Health Questionnaire-9
L??we, B., Un??tzer, J., Callahan, C. M., Perkins, A. J., & Kroenke, K. (2004) · Medical Care · doi:10.1097/00005650-200412000-00006 · Cited by 1,354
Self-citationLOWE, B. (2004) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00237-9 · Cited by 1,060
Kroenke, K., Wu, J., Bair, M. J., Krebs, E. E., Damush, T. M., & Tu, W. (2011) · The Journal of Pain · doi:10.1016/j.jpain.2011.03.003 · Cited by 573
Self-citationBair, M. J., Wu, J., Damush, T. M., Sutherland, J. M., & Kroenke, K. (2008) · Psychosomatic Medicine · doi:10.1097/psy.0b013e318185c510 · Cited by 572
“64 Black 109 (40) 6 (40) 30 (31) 46 (40) Other 8 (3) 0 (0) 5 (5) 5 (4) Married, n (%) 108 (40) 8 (53) 32 (33) 41 (35) .”
InfluentialSelf-citation
Metadata
- Authors
- Kroenke, K., West, S. L., Swindle, R., Gilsenan, A., Eckert, G. J., Dolor, R., Stang, P., Zhou, X.-H., Hays, R., & Weinberger, M.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2001-12-19
- Volume
- 286
- Issue
- 23
- Pages
- 2947
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2169496899
- Cited by
- 312
- References
- 27
- FWCI
- 14.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.